A meta-analysis of interleukin-6 promoter polymorphisms on risk of hip and knee osteoarthritis
- 31 May 2010
- journal article
- research article
- Published by Elsevier BV in Osteoarthritis and Cartilage
- Vol. 18 (5), 699-704
- https://doi.org/10.1016/j.joca.2009.12.012
Abstract
No abstract availableKeywords
Funding Information
- EC framework 7 programme (200800)
- Arthritis Research Campaign (UK)
- Medical Research Council (UK)
- Oxford NIHR Musculoskeletal Biomedical Research Unit
- Estonian Science Foundation (5308)
- Estonian Ministry of Social Affairs (9.6-4/2035, 12.1-5/597)
- AstraZeneca Macclesfield UK
This publication has 19 references indexed in Scilit:
- Desirable effect of combination therapy with high molecular weight hyaluronate and NSAIDs on MMP productionOsteoarthritis and Cartilage, 2009
- Attempt to replicate published genetic associations in a large, well-defined osteoarthritis case–control population (the GOAL study)Osteoarthritis and Cartilage, 2009
- Interleukin‐6 is a significant predictor of radiographic knee osteoarthritis: The Chingford studyArthritis & Rheumatism, 2009
- Osteoblasts derived from osteophytes produce interleukin-6, interleukin-8, and matrix metalloproteinase-13 in osteoarthritisJournal of Bone and Mineral Metabolism, 2009
- Polymorphisms in the interleukin‐1 receptor antagonist and interleukin‐6 genes affect risk of osteolysis in patients with total hip arthroplastyArthritis & Rheumatism, 2008
- Common interleukin-6 promoter variants associate with the more severe forms of distal interphalangeal osteoarthritisArthritis Research & Therapy, 2008
- Association of interleukin‐6 and interleukin‐10 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody statusArthritis & Rheumatism, 2007
- IL-6 promoter polymorphisms in rheumatoid arthritisGenes & Immunity, 2000
- The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.JCI Insight, 1998
- Role of interleukin‐1, tumor necrosis factor α, and interleukin‐6 in cartilage proteoglycan metabolism and destruction effect of in situ blocking in murine antigen‐ and zymosan‐induced arthritisArthritis & Rheumatism, 1995